Processing Your Payment
Please do not leave this page until complete. This can take a few moments.
Your search found 63 results
-
August 13, 2019 -Holliston biotech Biostage said Tuesday it plans to file with the U.S. Food & Drug Administration in September to kick-start the company’s clinical trials of its esophagus implant.
August 13, 2019 -Holliston biotech Biostage said Tuesday it plans to file with the U.S. Food & Drug Administration in September to kick-start the company’s clinical trials of its esophagus implant.
February 18, 2019 -Women continue to be vastly outnumbered by men at Central Mass. public companies, though improvement has been found in some areas.
February 18, 2019 -Women continue to be vastly outnumbered by men at Central Mass. public companies, though improvement has been found in some areas.
-
January 28, 2019 -
Holliston biotech Biostage is planning U.S. regulatory filings to begin marketing its esophagus-regenerating implants after a single-patient case in 2017 proved the company's technology works.
January 28, 2019 -Holliston biotech Biostage is planning U.S. regulatory filings to begin marketing its esophagus-regenerating implants after a single-patient case in 2017 proved the company's technology works.
November 8, 2018 -Holliston biotech startup Biostage has added three new members to its board of directors simultaneous to its third-quarter earnings report showing a slower cash burn.
November 8, 2018 -Holliston biotech startup Biostage has added three new members to its board of directors simultaneous to its third-quarter earnings report showing a slower cash burn.
November 6, 2018 -Holliston biotech Biostage has been awarded $1.1 million as part of a second phase of a fast-track small business grant to help the company's throat implant products make it to market.
November 6, 2018 -Holliston biotech Biostage has been awarded $1.1 million as part of a second phase of a fast-track small business grant to help the company's throat implant products make it to market.
August 15, 2018 -Despite just $5.8 million in cash to its name, Holliston organ bioengineering firm Biostage is eyeing a 2019 U.S. Food and Drug Administration application for its esophagus-regenerating device.
August 15, 2018 -Despite just $5.8 million in cash to its name, Holliston organ bioengineering firm Biostage is eyeing a 2019 U.S. Food and Drug Administration application for its esophagus-regenerating device.
August 13, 2018 -Holliston biotech Biostage is seeking to withdraw a registration statement with the SEC filed nearly one year ago after no securities had been issued or sold under the statement.
August 13, 2018 -Holliston biotech Biostage is seeking to withdraw a registration statement with the SEC filed nearly one year ago after no securities had been issued or sold under the statement.
June 1, 2018 -A former Bank of America executive who helped the company secure millions in foreign investments has been named the new president of Biostage in Holliston.
June 1, 2018 -A former Bank of America executive who helped the company secure millions in foreign investments has been named the new president of Biostage in Holliston.
May 25, 2018 -Biostage has named another Chinese executive to its board of directors as it seeks to remake itself and explore new markets in different parts of the world.
May 25, 2018 -Biostage has named another Chinese executive to its board of directors as it seeks to remake itself and explore new markets in different parts of the world.
May 4, 2018 -Holliston biotech firm Biostage has landed another large private investment of $3.6 million as it continues to pursue growth in Asian markets.
May 4, 2018 -Holliston biotech firm Biostage has landed another large private investment of $3.6 million as it continues to pursue growth in Asian markets.
April 2, 2018 -Holliston biotech Biostage ended 2017 with about $4 million in cash on hand, and that will carry the company only partially through this year's third quarter.
April 2, 2018 -Holliston biotech Biostage ended 2017 with about $4 million in cash on hand, and that will carry the company only partially through this year's third quarter.
March 30, 2018 -Holliston medical device maker Biostage has added another children's hospital executive as the company continues to remake itself into a child-focused biotech company.
March 30, 2018 -Holliston medical device maker Biostage has added another children's hospital executive as the company continues to remake itself into a child-focused biotech company.
March 29, 2018 -Funding for Biostage's bioengineered throat organ implants continues to pile up, as the Holliston company announced Thursday it has been awarded a grant worth up to $1.7 million.
March 29, 2018 -Funding for Biostage's bioengineered throat organ implants continues to pile up, as the Holliston company announced Thursday it has been awarded a grant worth up to $1.7 million.
March 13, 2018 -Holliston biotech Biostage is eyeing formal clinical trials after results of a large animal study show the company's artificial throat implants can regenerate a functioning esophagus.
March 13, 2018 -Holliston biotech Biostage is eyeing formal clinical trials after results of a large animal study show the company's artificial throat implants can regenerate a functioning esophagus.
February 13, 2018 -Biostage, a Holliston-based biotech specializing in regenerative medicine to treat diseases of the throat, announced on Tuesday its first esophageal implant resulted in a regenerated esophageal tube.
February 13, 2018 -Biostage, a Holliston-based biotech specializing in regenerative medicine to treat diseases of the throat, announced on Tuesday its first esophageal implant resulted in a regenerated esophageal tube.
